Related Experiment Video
Updated: Feb 25, 2026

Evaluation of Left Ventricular Structure and Function using 3D Echocardiography
Published on: October 28, 2020
Association of Concentric Left Ventricular Hypertrophy With Subsequent Change in Left Ventricular End-Diastolic
Sonia Garg1, James A de Lemos2, Susan A Matulevicius2
1From the Division of Cardiology, Department of Internal Medicine (S.G., J.A.d.L., S.A.M., A.P., I.J.N., J.D.B., M.H.D.), Department of Clinical Science (C.A., J.D.B.), and Department of Radiology (R.M., C.M., R.M.P.), University of Texas Southwestern Medical Center, Dallas. sonia.garg@utsouthwestern.edu.
Insights
Concentric hypertrophy, a thickened left ventricle (LV), showed a slight increase in LV end-diastolic volume over 7 years without heart attacks. Progression to dilated cardiomyopathy was rare, suggesting a much longer development time.
Area of Science:
- Cardiology
- Cardiovascular Research
- Cardiac Imaging
Background:
- The conventional view suggests left ventricular hypertrophy (LVH) progresses to dilated cardiomyopathy.
- Limited human data exist on this transition without myocardial infarction.
- Investigating the progression of LVH without prior cardiac events is crucial.
Purpose of the Study:
- To examine the association between concentric hypertrophy and left ventricular (LV) dilation over time.
- To determine if LVH commonly progresses to dilated cardiomyopathy in the absence of myocardial infarction.
- To assess the rate of LV end-diastolic volume (EDV) change in individuals with and without concentric hypertrophy.
Main Methods:
- Serial cardiac magnetic resonance imaging (CMR) was performed on 1282 participants from the Dallas Heart Study approximately 7 years apart.
- Participants with interval cardiovascular events or baseline dilated LV were excluded.
- Multivariable linear regression models analyzed the link between baseline concentric hypertrophy and changes in LV end-diastolic volume (LVEDV).
Main Results:
- 11% of participants (n=142) had baseline concentric hypertrophy.
- Concentric hypertrophy was associated with a significantly greater increase in LVEDV (1 mL) compared to those without (-2 mL) over 7 years (P<0.01).
- Progression to a dilated LV was uncommon, observed in only 2% (n=25) of the cohort.
Conclusions:
- Concentric hypertrophy is linked to a small but significant increase in LVEDV over 7 years, independent of myocardial infarction.
- The observed LV enlargement was minimal, and progression to dilated LV was infrequent.
- These findings suggest that the transition from concentric hypertrophy to dilated cardiomyopathy may take decades and is less common than previously assumed.
Background:
In the conventional paradigm of the progression of left ventricular hypertrophy, a thick-walled left ventricle (LV) ultimately transitions to a dilated cardiomyopathy. There are scant data in humans demonstrating whether this transition occurs commonly without an interval myocardial infarction.
Methods And Results:
Participants (n=1282) from the Dallas Heart Study underwent serial cardiac magnetic resonance ≈7 years apart. Those with interval cardiovascular events and a dilated LV (increased LV end-diastolic volume [EDV] indexed to body surface area) at baseline were excluded. Multivariable linear regression models tested the association of concentric hypertrophy (increased LV mass and LV mass/volume0.67) with change in LVEDV. The study cohort had a median age of 44 years, 57% women, 43% black, and 11% (n=142) baseline concentric hypertrophy. The change in LVEDV in those with versus without concentric hypertrophy was 1 mL (-9 to 12) versus -2 mL (-11 to 7), respectively, P<0.01. In multivariable linear regression models, concentric hypertrophy was associated with larger follow-up LVEDV (P≤0.01). The progression to a dilated LV was uncommon (2%, n=25).
Conclusions:
In the absence of interval myocardial infarction, concentric hypertrophy was associated with a small, but significantly greater, increase in LVEDV after 7-year follow-up. However, the degree of LV enlargement was minimal, and few participants developed a dilated LV. These data suggest that if concentric hypertrophy does progress to a dilated cardiomyopathy, such a transition would occur over a much longer timeframe (eg, decades) and perhaps less common than previously thought.
Clinical Trial Registration:
URL: http://www.clinicaltrials.gov. Unique identifier: NCT00344903.
Related Concept Videos
Heart Failure II: Pathophysiology
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Regurgitation I: Introduction
Imbalances in Cardiac Output
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...

